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Abstract: Chorioamnionitis, clinically most frequently associated with Ureaplasma, is linked
to intestinal inflammation and subsequent gut injury. No treatment is available to prevent
chorioamnionitis-driven adverse intestinal outcomes. Evidence is increasing that plant sterols
possess immune-modulatory properties. Therefore, we investigated the potential therapeutic effects
of plant sterols in lambs intra-amniotically (IA) exposed to Ureaplasma. Fetal lambs were IA exposed
to Ureaplasma parvum (U. parvum, UP) for six days from 127 d–133 d of gestational age (GA). The plant
sterols β-sitosterol and campesterol, dissolved with β-cyclodextrin (carrier), were given IA every
two days from 122 d–131 d GA. Fetal circulatory cytokine levels, gut inflammation, intestinal injury,
enterocyte maturation, and mucosal phospholipid and bile acid profiles were measured at 133 d GA
(term 150 d). IA plant sterol administration blocked a fetal inflammatory response syndrome. Plant
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sterols reduced intestinal accumulation of proinflammatory phospholipids and tended to prevent
mucosal myeloperoxidase-positive (MPO) cell influx, indicating an inhibition of gut inflammation.
IA administration of plant sterols and carrier diminished intestinal mucosal damage, stimulated
maturation of the immature epithelium, and partially prevented U. parvum-driven reduction of
mucosal bile acids. In conclusion, we show that β-sitosterol and campesterol administration protected
the fetus against adverse gut outcomes following UP-driven chorioamnionitis by preventing intestinal
and systemic inflammation.
Keywords: chorioamnionitis; Ureaplasma parvum; ovine; plant sterols; β-sitosterol; campesterol; fetal
inflammatory response syndrome; intestinal inflammation; intestinal lipidome
1. Introduction
Preterm birth is the leading cause of neonatal mortality and morbidity, and it accounts for 35% of
neonatal deaths worldwide [1]. Annually, 15 million children are born prematurely, an incidence that is
still increasing [2]. Chorioamnionitis, defined as inflammatory cell infiltration of fetal membranes, is an
important cause of preterm birth [3]. During chorioamnionitis, contaminated amniotic fluid (AF) is
swallowed by the fetus, consequently infecting the gastrointestinal system. We have previously studied
the effects of chorioamnionitis on the fetal gut in a translational ovine chorioamnionitis model that is
of relevance to human pathology because of the close resemblance between the developmental biology
and physiology of human and ovine fetuses [4]. In this model, intra-amniotic (IA) infections with
micro-organisms and inflammatory mediators (lipopolysaccharide (LPS)) can induce gut inflammation
and subsequent gut injury and developmental alterations [5,6]. Accordingly, chorioamnionitis is
associated with an increased risk of postnatal intestinal pathologies, such as necrotizing enterocolitis
(NEC), which is known for its high mortality and morbidity rates [7–9]. In addition, chorioamnionitis is
associated with the fetal inflammatory response syndrome (FIRS), which is characterized by increased
IL-6 concentrations in fetal blood and is an independent risk factor for severe neonatal morbidity [10].
Currently, no treatments are able to prevent intestinal inflammation and its sequelae following
chorioamnionitis or to consequently prevent postnatal intestinal disorders [9]. Plant sterols, also known
as phytosterols, are a dietary component derived from vegetable oils, fruits, nuts, and grains [11].
They were first evaluated in the atherosclerosis field for their cholesterol-lowering effects [12].
In addition, their immune-regulatory potential has been increasingly recognized [13]. Recently,
these plant sterols were shown to possess anti-inflammatory properties in the context of intestinal
inflammatory diseases such as inflammatory bowel disease [14–16]. Interestingly, this was recently
confirmed in a small pilot study in fetal lambs, in which intestinal inflammation and mucosal injury
following IA LPS exposure were prevented by plant sterol treatment [17].
This pilot study prompted us to conduct the current in-depth study, in which chorioamnionitis
was induced by viable U. parvum serovar 3, the micro-organism most frequently associated with
chorioamnionitis. UP, a mycoplasma present in the female urogenital tract [18], inflicts a milder hit
than LPS does. Nevertheless, UP colonization in preterm infants has been found to increase NEC
incidence twofold, with a gestational age-adjusted odds ratio (OR) of 2.47 (95% CI, 1.13–5.43) [19,20],
making UP a clinically relevant stressor.
We IA-administered a mixture of β-sitosterol and campesterol, the two most common plant sterols
in nature [11], as a treatment prior to IA injection of UP serovar 3. The effects of plant sterol treatment in
the context of UP-induced chorioamnionitis were investigated by studying circulatory cytokine levels,
fetal gut inflammation, intestinal delivery of the plant sterols, and intestinal injury and maturation.
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2. Materials and Methods
2.1. Experimental Design
The animal studies were approved by the Animal Ethics Committee of the University of Western
Australia (Perth, Australia), and the National Research Council’s guide for the care and use of laboratory
animals was followed. Time-mated Merino cross-breed ewes with singleton fetuses were randomly
assigned to the 6 study groups. A total number of 50 animals were used, based on a power analysis
with intestinal inflammation as the primary outcome.
Following drop-outs, the group size for data analyses was six to seven animals per group (Figure 1).
Animals were group-housed with a 12-h dark/light cycle and had ad libitum access to food and water.
Animal welfare was assessed daily by qualified personnel. The experiment was reported to be in
compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines [21].Nutrients 2019, 11, x FOR PEER REVIEW 4 of 21 
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Figure 1. Experimental design. Animals were randomly assigned to six study groups of six to seven
animals. Plant sterols dissolved with a carrier (C) (β-cyclodextrin) were given by intra-amniotic (IA)
injection at 122 d of gestational age (GA), before onset of chorioamnionitis. Plant sterol injections were
repeated every 2 days until 131 d GA, followed by premature delivery at 133 d GA. U. parvum serovar 3
(107 color changing units (CCUs)) was given by IA injection at 127 d GA to induce chorioamnionitis.
Control groups had saline injections. Two groups received the carrier (β-cyclodextrin) IA without
plant sterols to assess the carrier separately from the plant sterols. Abbreviations: C, carrier; IA,
intra-amniotic; S, plant sterols; UP, U. parvum.
To investigate whether plant sterols can be used as a nutritional intervention in utero to improve
fetal outcomes in the context of chorioamnionitis, we deliberately chose IA administration, since the
pharmacokinetics of plant sterols in sheep are to date unclear. In addition, several findings have
supported the concept that plant sterol availability to the fetus is determined by the maternal diet.
First, plant sterols are not synthesized by animals and humans and are exclusively gained through the
diet [22]: The natural presence of plant sterols in AF thus implies that maternal diet-derived plant
sterols reach the AF [23,24]. Second, the plant sterol transporter NPC1L1 is present in the human
placenta [22,25]. Finally, a meta-analysis from Ras et al. reported that oral plant sterol administration
increases plasma plant sterol concentrations [26]. Therefore, increasing plant sterol levels in the
maternal diet is clinically the most relevant route of administration.
Therefore, we enriched the AF of pregnant ewes as a model for AF enrichment following maternal
oral plant sterol intake. A mixture of β-sitosterol (70%) and campesterol (30%) (total of 0.6 mg/mL)
dissolved in a carrier, 18% 2-hydroxypropyl-β-cyclodextrin (H107, Sigma Aldrich, St. Louis, MO,
USA) in saline, carrier in saline, or saline alone was injected IA at 122 d of gestational age (GA),
five days before IA UP injection. This dosage was chosen to supplement endogenous plant sterol
concentration, starting with a twofold increase. Since the plant sterol mixture was hydrophobic,
the carrier β-cyclodextrin was essential in dissolving the plant sterols (transport). Animals were
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injected every two days with additional IA injections containing saline or a plant sterol mixture
until 131 d GA. AF samples were collected every 2 days from 122 d GA until preterm delivery at
133 d GA. Viable U. parvum serovar 3 (107 color changing units (CCUs)) or saline was given IA at
127 d of gestational age (GA). UP was grown in vitro and injected into the AF under ultrasound
guidance as reported previously [27]. AF sampled at 133 d GA was cultured for UP enumeration [28].
Colonization of UP was not detected in the AF of controls. Fetuses were delivered preterm by caesarean
section at 133 d GA (150 d ~ term), which is (with regard to the gut) comparable to 33–34 weeks
of human gestation. Lambs were euthanized directly after delivery by an intravenous injection of
pentobarbitone (100 mg/kg, Valaberb, Pitman-Moore, Australia). Distal ileum and blood samples for
obtaining plasma were collected postmortem. The investigators involved in the data analyses were
blinded to treatment allocation.
2.2. Antibodies
The following antibodies were used: polyclonal rabbit antibody against human myeloperoxidase
(MPO) (A0398, Dakocytomation, Glostrup, Denmark) and cluster of differentiation 3 (CD3 (A0452,
Dakocytomation, Glostrup, Denmark), monoclonal rabbit antibody against human fork head box
P3 (FoxP3) (clone eBio7979, 14-7979-82, eBioscience, San Diego, CA, USA), ovine interleukin-6
(IL-6) (MAB1004, Millipore, Darmstadt, Germany), and ovine IL-8 (MAB1044 Millipore, Darmstadt,
Germany). Antibodies against intestinal fatty acid binding protein (I-FABP) were kindly provided
by the Department of Surgery, Maastricht University Medical Centre, the Netherlands. Secondary
antibodies were the following: biotin-conjugated rabbit antimouse (E0413, DakoCytomation, Glostrup,
Denmark), swine antirabbit (E0353, DakoCytomation, Glostrup, Denmark), and peroxidase-conjugated
goat antirabbit (111-035-045, Jackson, West Grove, PA, USA). Detection antibodies against IL-6 (AB1839,
Millipore, Darmstadt, Germany) and IL-8 (AB1840, Millipore, Darmstadt, Germany) were used.
2.3. ELISA
Plasma I-FABP concentrations were assessed by ELISA. A high-sensitivity ELISA kit was kindly
provided by the Department of Surgery, Maastricht University Medical Centre, the Netherlands.
The protocol used was as described previously [29]. Circulatory IL-6 and IL-8 concentrations were
measured to assess whether systemic inflammation was present as previously described [30]. Briefly,
a 96-well plate (ELISA 96-well, Greiner Bio One) was precoated with 100 µl of IL-6 (5 µg/mL) or IL-8
(5 µg/mL) antibodies overnight at 4 ◦C. After incubation and washing, nonspecific binding sites were
blocked. For the standard curve, protein standards were prepared by two-step serial dilutions of
recombinant IL-6 or IL-8 (ImmunoChemistry Technologies, Bloomington, MN, USA). Diluted plasma
samples and protein standards were added in duplicate and incubated for 2 h at 37 ◦C. After washing,
detection antibodies were added for one hour at room temperature (RT). Detection antibodies against
IL-6 or IL-8 were detected using a peroxidase-conjugated antibody and 3,3′,5,5′-tetramethylbenzidine
(TMB) substrate solution (Sigma Aldrich, St. Louis, MO, USA).
2.4. Immunohistochemistry
We fixed distal ileum in 4% paraformaldehyde, embedded it in paraffin, and cut 4-um sections
with a Leica RM2235 microtome to perform immunohistochemistry studies. Intestinal mucosal damage
and morphological changes were assessed using hematoxylin and eosin staining (H&E). Per animal,
a histological score was assigned to the intestinal section by 2 blinded investigators. The following
scoring system (from no injury to severe injury) was developed to describe the severity of histological
injury: no damage, mild damage (disrupted epithelial lining, but no loss of enterocytes), moderate
damage (disrupted epithelial lining, moderate enterocyte loss from the villus tips), or severe damage
(a disrupted epithelial lining, abundant enterocyte loss from villus tips).
Sections were stained for CD3, FoxP3, MPO, and I-FABP as described previously [6]. Briefly,
endogenous peroxidase activity was blocked with 0.3% H2O2 in phosphate-buffered saline. For CD3,
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antigen retrieval was performed by boiling in 10 mM of sodium-citrate buffer (pH 6.0) for 10 min.
Blocking of nonspecific binding sites was performed with normal goat serum (MPO) or bovine serum
albumin (CD3, FoxP3, I-FABP) for 30 min at room temperature. Subsequently, slides were incubated
with the primary antibody of interest for one hour at room temperature (MPO) or overnight at 4 ◦C
(CD3, FoxP3, I-FABP). After washing, slides were incubated with biotin-conjugated (CD3, FoxP3)
or peroxidase-conjugated secondary antibodies (MPO, I-FABP). MPO and I-FABP positivity was
visualized with 3-amino-9-ethylcarbazole (AEC, Sigma Aldrich, St. Louis, MO, USA). CD3- and
FoxP3-positive cells were detected using nickel-3,3′-diaminobenzidine (Sigma Aldrich, St. Louis, MO,
USA). Nuclei were counterstained with hematoxylin (MPO and I-FABP) or with nuclear fast red (CD3
and FoxP3). The number of MPO-, CD3-, and Foxp3-positive cells were counted per high power fields
(100x) using a light microscope (Leica Microsystem CTG, type DFC295) and ImageJ (1.52b software,
National Institutes of Health, Bethesda, MD, USA). For MPO, the number of MPO+ cells present in the
villi was determined separately, and the percentage of MPO+ cells in the villi compared to the total
MPO+ cell count was determined. The average value of five representative high power fields was
used for the analyses.
2.5. Gas–Liquid Chromatography–Mass Spectrometry (GC-MS)
Plant sterols (β-sitosterol and campesterol), cholesterol and cholesterol precursor (desmosterol
and lathosterol) concentrations in plasma (lathosterol), and AF samples (demosterol and lathosterol)
were measured using gas chromatography–mass spectrometry as described previously [12].
2.6. Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging
To study the distribution and changes in intestinal lipid profiles in more detail, molecular analysis
of the distal ileum (n = 3 per group) was performed by matrix-assisted laser desorption ionization mass
spectrometry imaging (MALDI-MSI). After sampling, the intestinal tissues of all treatment groups
(control, sterol + carrier, carrier, 6-d UP, 6-d UP + sterol + carrier, and 6-d UP + carrier) were frozen
in liquid nitrogen, and cryo-sections of 10 µm were cut in a cryostat (Leica CM3050S, Amsterdam,
The Netherlands). The tissue sections were deposited on indium tin oxide conductive slides (Delta
Technologies, Loveland, CO, USA) and stored at −20 ◦C. A matrix solution consisting of norharman
(7 mg/mL) in 2:1 chloroform/methanol was sprayed on top of the tissue sections by using a TM-Sprayer
M3 (HTX Technologies, Carrboro, NC, USA). The imaging experiments were performed with a Bruker
RapifleX MALDI Tissuetyper in reflectron mode (Bruker Daltonik GmbH, Bremen, Germany) at a
raster size of 80 µm. Data were acquired in positive ion mode in the mass range m/z 300–1600 and in
negative ion mode in the mass range m/z 350–1600. Each tissue section was used for both polarities,
with an offset of 40 µm in the X/Y directions. High spatial resolution experiments were performed
using 5 mg/mL of α-cyano-4-hydroxycinnamic acid (Sigma Aldrich, St. Louis, MO, USA) in 70%
acetonitrile and 0.2% trifluoroacetic acid and were sprayed with a SunCollect sprayer (SunChrom).
Data were acquired in positive mode with a MALDI HDMS SYNAPT G2-Si mass spectrometer (Waters,
Manchester, UK) with a modified MALDI source unit, which achieves a laser spot 15 µm in diameter
at a spatial resolution of 20 µm [31]. Lipid identifications were obtained using a high-mass resolution
MALDI-MSI Orbitrap Elite Hybrid Ion trap mass spectrometer (Thermo Fisher Scientific, Bremen,
Germany). Tandem Mass Spectrometry (MS/MS) spectra (Table S1) were submitted to the ALEX123
lipid database (http://alex123.info/ALEX123/MS.php). To study differences between all conditions,
principal component analyses (PCAs) and discriminant analysis (DA) were performed. Both the PCAs
and DA were performed by using an in-house built ChemomeTricks toolbox for MATLAB version
2014a (MathWorks, Natick, MA, USA). For analyzing lipid patterns in the intestinal epithelium, luminal
lipid signals were excluded from the data analyses. Only for an analysis of β-cyclodextrin presence
were luminal signals included.
Nutrients 2019, 11, 968 6 of 21
2.7. Statistics
Statistical analyses were performed using GraphPad Prism software (version v6.0, GraphPad
Software Inc., La Jolla, CA, USA). Data are presented as the median with an interquartile range (IQR)
for all read-outs, except for the damage score, where only the median is presented. A nonparametric
Kruskal–Wallis test followed by Dunn’s post hoc test was used to analyze significant differences
between the groups. Differences were regarded as statistically significant at p < 0.05: p-values ≤ 0.1
were interpreted as biologically relevant, as previously described [32].
3. Results
3.1. Systemic and Intestinal Inflammation
3.1.1. Systemic Inflammation
Plant sterol treatment before and during UP exposure significantly lowered systemic IL-6
concentrations compared to UP-exposed animals (p < 0.05) (Figure 2). No significant changes were
observed in IL-8 plasma concentrations among the several treatment groups (Supplementary Materials,
Figure S1).
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Figure 2. Circulatory IL-6 levels in fetuses of 133 d GA. Plant sterols significantly inhibited circulatory
IL-6 levels. * p < 0.05. Abbreviations: GA, gestational age; UP, U. parvum.
3.1.2. Intestinal inflammation
The percentage of MPO-positive cells that migrated into the villi in the distal ileum increased
significantly after 6 d of UP exposure (p < 0.05) compared to control animals (Figure 3A,B,D).
This increase tended to be reduced (p = 0.10) by plant sterols (Figure 3C,D). The number of FoxP3+ and
CD3+ cells did not differ with statistical significance between the experimental groups (Figure 4A,B).
The FoxP3+/CD3+ ratio tended to be reduced in fetuses exposed to UP (p = 0.06), which was not
restored by plant sterol treatment. Remarkably, plant sterol treatment alone also tended to reduce the
FoxP3+/CD3+ ratio (p = 0.09) (Figure 4C).
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3.2. UP and Sterol Concentrations in Amniotic Fluid
UP infection was confirmed by the presence of UP in the AF of ewes injected with UP
(Supplementary Materials, Figure S2). No statistically significant differences were observed in
UP CCUs between the three treatment groups. No UP CCUs were present in the AF of animals that
were not injected with UP.
IA concentrations of β-sitosterol in the sterol group increased with repeated doses and were
statistically significantly (p < 0.05) elevated compared to controls at 133 d GA, indicating the
accumulation of β-sitosterol over time with IA delivery (Figure 5A). Here, β-sitosterol concentrations
were not statistically significantly increased in the 6-d UP group treated with plant sterols at 133 d GA.
The AF campesterol concentration tended to be increased (p = 0.09) at 133 d GA in ewes that were treated
with IA plant sterols compared to control ewes (Figure 5B). Campesterol was not statistically significantly
elevated in the AF of ewes that were exposed to UP and plant sterols at 133 d GA. No statistically
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significant differences were found in lathosterol, desmosterol, and cholesterol concentrations in the AF
between treatment groups (Supplementary Materials, Figure S3).
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Figure 5. AF concentrations of β-sitosterol and campesterol. AF samples were taken every two
days from 122 d GA until preterm delivery at 133 d GA. (A) AF concentrations of β-sitosterol were
significantly increased at day 11 in the sterol + carrier group. (B) AF concentrations of campesterol
tended to be increased at day 11 in the sterol + carrier group. Day 0 (122 d GA) is the start of plant
sterol treatment, day 5 (127 d GA) is the day of intra-amniotic UP injection, and day 11 (133 d GA)
is the moment of preterm delivery. * p < 0.05; # 0.05 < p < 0.10. Abbreviations: AF, amniotic fluid;
GA, gestational age; UP, U. parvum.
3.3. Sterol Concentrations in Fetal Plasma
Fetal plasma concentrations of β-sitosterol and campesterol in the sterol-supplemented groups
were not significantly elevated at 133 d GA compared to the other groups (Figure 6A,B). Lathosterol
concentrations were statistically significantly decreased after 6 d of UP exposure with plant sterol
treatment (p < 0.05) and tended to be decreased after 6 d of UP exposure alone (p = 0.10) compared to
the control animals (Figure 6C). The changes in plasma lathosterol concentrations did not result in
altered plasma cholesterol concentrations in the different experimental groups (Figure 6D).
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blocked by the administration of plant sterols (only two out of six had moderate to severe damage) 
and the carrier (three out of seven had moderate to severe damage) (Figure 7C,D; Supplementary 
Materials, Figure S4). No changes were observed in fetal plasma concentrations of I-FABP 
(Supplementary Materials, Figure S5), a small protein present in the cytoplasm of mature enterocytes. 
Furthermore, the sizes of enterocyte vacuoles were increased in all experimental groups when 
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Figure 6. Circulatory β-sitosterol, campesterol, lathosterol (cholesterol precursor), and cholesterol
levels in lambs of 133 d GA (preterm delivery). No significant differences were found for β-sitosterol
(A) and campesterol (B) in all treatment groups. (C) UP exposure with and without plant sterol
treatment reduced lathosterol plasma concentrations compared to controls. (D) Plasma cholesterol
concentrations were not affected by UP exposure and/or plant sterol treatment. * p < 0.05; # 0.05 < p <
0.10. Abbreviations: GA, gestational age; UP, U. parvum.
3.4. Intestinal Damage and Gut Maturation
Enterocyte loss at the villi tips in H&E stained ileal tissue, indicating oderate to severe intestinal
damage, was found in five out of seven of the 6-d UP-expos d lambs, comp red to one out of six
contro s (Figure 7A,B; Supplementary Ma ials, Figure S4). Intestinal damage wa pa tly blocked by
the administration of plant sterols (o ly two ut of six had moder t to severe damage) and the carrier
(three out of seven had moderate to severe damage) (Figure 7C,D; Supplementary Materials, Figure
S4). No changes were observed in fetal plasma concentrations of I-FABP (Supplementary Materials,
Figure S5), a small protein present in the cytoplasm of mature enterocytes. Furthermore, the sizes of
enterocyte vacuoles were increased in all experimental groups when compared to control animals
(Figure 7A–D).
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To assess enterocyte maturation, the distribution of I-FABP was analyzed in the distal ileum.
I-FABP expression was altered in the 6-d UP-exposed fetuses compared to controls, as expression was
more localized in the intestinal crypts (Figure 8A,B). This disturbed I-FABP distribution was partially
restored by carrier administration (Figure 8C) as well as by plant sterol treatment (Figure 8D).
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3.5. Changes in Lipid Profiles in the Fetal Gut
ALDI- SI as used for the follo ing reasons: (1) to study changes in the orphological
appearance of the vacuolated enterocytes after plant sterol treatment, (2) as an additional read-out
for inflammation, and (3) to confirm that plant sterols were delivered in the fetal intestinal lu en
follo ing IA plant sterol ad inistration. Interestingly, lipid co position as changed after 6 d UP
exposure co pared to the other treatment groups and was characterized by an increased presence
of different phosphatidylcholines (PCs) and sphingomyelins (SMs), as the first discri inant function
(DF1) shows (Figure 9A–C). A clear accumulation of m/z 782.58 PC 34:1 [M + Na]+ was detected in the
6-d UP group compared to the control situation (Figure 9C). Furthermore, m/z 810.60 PC 36:1 [M + Na]+
and m/z 725.57 SM 34:1 [M + Na]+ were also enriched in the 6-d UP group lipid profile (Figure 9B).
These UP-induced changes of the intestinal lipidome were partially reduced by plant sterols and/or the
carrier (Figure 9D–G). The carrier was characterized by m/z 1331.52 [M + Na]+ and was confirmed by
tande MS [33]. Other peaks related to the carrier, such as m/z 1273.48, m/z 1389.55, and m/z 1447.59,
were also detected in the intestinal epithelium of the sterol + carrier, carrier, UP + sterol + carrier, and
UP + carrier groups (Figure 9F,G). The presence of the carrier was mainly detected in the intestinal
lumen in all carrier and plant sterol groups (sterol + carrier, carrier, 6-d UP + sterol + carrier, and 6-d
UP + carrier), but not in the control and 6-d UP groups (Figure 10), showing intraluminal delivery and
subsequent uptake in the distal ileum.
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Figure 9. Matrix-assi ted laser desorption ization mass spectromet y imaging performed in positive
ion mode followed by principal component analysis. The first discriminant function is sh wn.
(A) Intestinal lipid compositi n wa changed after 6 UP exposure compared t the other treatment
g oups, (B,C) with increased presence of diffe nt PCs an SMs i the 6-d UP group, including m/z 782.58
PC 34:1 [M + Na]+, m/z 810.60 PC 36:1 [M + Na]+, and m/z 725.57 SM 34:1 [M + Na]+. (D–G) These
UP-induced changes the intesti al lipidome were partially normalized by pla t sterols and/or the
car ier. The carri r (2-hydroxyp opyl-β-c cl dextrin), chara terized by m/z 1331.52 [M + Na]+, m/z
1389.55, and m/z 1447.59, was detected in th intestinal epith lium of the 6-d UP + sterol + carrier
and th 6-d UP + carrier groups. Abbreviations: PCs, phosphocholines; SMs, sphingomyelins; UP,
. parvum.
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Lipid species, including phosphatidylinositols (PIs) and bile acids (BAs), were identified in the
negative ion mode by using MALDI-MSI (Figure 11). In line with the results in the positive ion
mode, the most profound lipidome changes were detected in the UP-exposed animals (Figure 11A).
More precisely, a higher abundance of m/z 885.58 PI 38:4 [M −H]− and a strong reduction of dihydroxy
BA m/z 498.29 taurodeoxycholic acid/taurochenodeoxycholic acid [M − H]− (TCDA/TCDCA) and
trihydroxy BA m/z 514.29 [M − H]− taurocholic acid (TCA) following UP infection were found, which
were indicative of a proinflammatory environment and a reduced BA status (Figure 11A,B). These
UP-induced lipidome and BA changes detected in the negative ion mode were partially prevented by
plant sterol and/or carrier administration (Figure 11C–F).
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4. Discussion 
An important finding was that IA plant sterol administration decreased the fetal systemic 
inflammatory response (circulatory IL-6 levels) during UP-driven chorioamnionitis. This 
corresponds with a study from Bouic et al. showing that a systemic inflammatory response following 
excessive exercise (increased serum IL-6 concentrations) was prevented by supplementing 
Figure 1 . Matrix-as isted laser desorption ionization mas spectrometry imaging performed in
negative ion mode followed by principal comp nent analysis. The first discriminant fu ction is shown.
(A) 6-d UP group animals showed an altered lipid profile compar d to the other tr atm nt groups,
(B) with a higher abundance of m/z 885.58 PI 38:4 [M−H]− and a reduced p sence of m/z 498.29 [M−H]−
dihydroxy BA TCDA/TCDCA and m/z 514.29 [M −H]− trihydroxy BA TCA. (C–F) In the 6-d UP + sterol
and 6-d UP + sterol + carrier groups, UP-induced lipi ome and BA changes were partially prevented
with a profile comparable to the controls. Abbreviations: BA, bile acid; PI, pho phatidylinositol; TCA,
taur cholic acid; TCDA, taurodeoxycholic a id; TCDCA, taurochenodeoxycholic; UP, U. parvum.
4. Discussion
An important finding was that IA plant sterol administration decreased the fetal systemic
inflammatory response (circulatory IL-6 levels) during UP-driven chorioamnionitis. This corresponds
with a study from Bouic et al. showing that a systemic inflammatory response following excessive
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exercise (increased serum IL-6 concentrations) was prevented by supplementing ultramarathon athletes
with capsules containing a mixture of plant sterols [34,35]. This decrease in systemic inflammation was
supported by work from Nashed et al., who showed that splenocytes cultured from plant sterol-treated
apo E-knockout mice reduced the production of IL-6 upon stimulation with LPS [36].
In addition, our data suggest that IA plant sterol treatment partially modulates fetal intestinal
inflammation in response to UP infection. This result is supported by a recent pilot study in which we
showed that IA plant sterol administration completely prevented mucosal neutrophil infiltration in
ovine fetuses IA exposed to LPS instead of UP [17]. In this study, IA LPS exposure provoked excessive
inflammation and severe epithelial injury. Such severe injury might be a prerequisite to better detect the
protective effects of plant sterols. In an earlier study of UP-induced chorioamnionitis, we reported that
intestinal inflammation after IA UP exposure was characterized by an imbalance between regulatory
T-cells (Treg) and effector T-cells [37]. This was confirmed in the current study, where we observed a
trend toward a reduced FoxP3+/CD3+ ratio with UP exposure. In our experiments, IA plant sterol
administration tended to decrease the FoxP3+/CD3+ ratio, indicating that IA plant sterol administration
may suppress the number of intestinal Tregs. Other studies have also reported the effects of plant sterols
on Treg cell numbers, although both increased and decreased Treg numbers have been observed. More
precisely, Te Velde et al. found an increase in Treg numbers and a decrease in total T-cell numbers in the
colon in a murine T-cell transfer colitis model after dietary plant sterol enrichment [14]. De Smet et al.
showed that oral administration of plant sterols reduced both Treg numbers and T-cell numbers in the
jejunum of healthy volunteers with a concomitant reduction in T-cell-associated gene expression [38].
This variation illustrates that the effect of plant sterols on T-cells is determined by the underlying
pathophysiology, intestinal region, timing of the intervention, duration, and nature of the inflammatory
stimulus and developmental stage.
Since plant sterols are known to influence cholesterol metabolism, which may be relevant to
fetal/neonatal growth and development [39], cholesterol and cholesterol precursor concentrations
in AF and plasma were studied. No changes were seen in AF and fetal plasma in the plant sterol
group compared to the control group, indicating that plant sterol administration did not disturb
systemic cholesterol concentrations or cholesterol synthesis in the fetus. The reason for the increased
size of enterocyte vacuoles following plant sterol and carrier supplementation remains unknown.
Interestingly, UP administration did reduce endogenous cholesterol synthesis, as reflected by reduced
fetal plasma lathosterol concentrations. The mechanisms by which IA UP exposure can influence
endogenous cholesterol synthesis are currently unclear. The disturbance of endogenous cholesterol
synthesis was not prevented by plant sterol administration.
In this study, we found an enrichment of phospholipids (i.e., phosphatidylcholines,
sphingomyelins, and phosphatidylinositol) [40–43] present in the cell membrane and involved in
diverse cell signaling processes following IA UP exposure. Interestingly, similar changes in the cerebral
lipodome were found by Gussenhoven et al. in ovine fetuses after two days of IA LPS exposure, and
these changes were indicative of an inflammation-induced “diseased” lipid profile [44]. Although
such lipid disturbances have been associated with detrimental effects on the central nervous system,
immune system, and skeletal muscles [45], the significance for the intestine is still unknown [46].
Besides changes in phospholipids, BAs were reduced in UP-exposed animals. BAs are critical to
the facilitation of dietary lipid absorption, intestinal antimicrobial defense [47,48], and regulation of
gastrointestinal motility [49,50]. A reduction of intestinal BA following antenatal UP exposure might
therefore subvert lipid malabsorption, microbial defense, and intestinal motility, which are known risk
factors for NEC development [51–53]. In line with this theory, an increased incidence of NEC has been
associated with UP infections [19,20].
Interestingly, in this study, plant sterols and/or the carrier reduced mucosal damage and stimulated
the maturation of enterocytes. Based on these data, we cannot define to what extent plant sterols
and/or the carrier are responsible for protective gut barrier/maturational effects, but several findings
have indicated that the effects are plant sterol-specific. First, as we recently showed, plant sterol
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administration, but not the carrier, prevented severe damage to the fetal gut following LPS-induced
chorioamnionitis [17]. Second, plant sterols prevent systemic inflammation, which is a known inducer
of gut integrity loss.
In this short-term proof of concept study, repetitive IA plant sterol injections induced a gradual
increase in AF plant sterol concentrations. This ultimately led to a 10-fold increase, which is likely
higher than can be expected following maternal oral administration of plant sterols. Further studies
are thus needed to explore the potential beneficial effects of a maternal oral nutritional intervention
with β-sitosterol and campesterol on the fetus over time.
In our study, we found therapeutic effects of the carrier β-cyclodextrin that were milder, but
which recapitulated the effects of β-cyclodextrin + plant sterols. Overlapping working mechanisms of
both plant sterols and β-cyclodextrin may explain these findings: β-cyclodextrin has previously been
shown to exert anti-inflammatory effects in the field of atherosclerosis [54–56], mediated (among other
things) by an increase in liver-X-receptor (LXR) target gene expression [56]. Interestingly, plant sterols
are also known activators of LXRs [57], and LXR signaling has been implicated in playing a role in
experimental colitis and inflammatory bowel disease [58,59]. As more prominent and exclusive effects
of plant sterols are seen when compared to carrier-only-treated animals, it is tempting to speculate that
plant sterols target LXR-independent pathways, which remains to be further elucidated.
5. Conclusions
In conclusion, we showed in this proof of concept study that IA β-sitosterol and campesterol
administration prevented fetal systemic and intestinal inflammation. Moreover, the combined results
from the LPS- and UP-induced chorioamnionitis models showed that plant sterols have the potential
to prevent intestinal mucosal injury. Future studies are required to investigate the pharmacokinetics of
plant sterols in the fetus following maternal intake during human pregnancy to further dissect the
role of plant sterols and the carrier in the protection of the fetal gut and ultimately unravel the clinical
potential of plant sterols in the perinatal context.
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CCU color changing units
DA discriminant analysis
FIRS fetal inflammatory response syndrome
FoxP3 fork head box P3
GA gestational age
GC-MS gas–liquid chromatography–mass spectrometry
H&E hematoxylin and eosin staining
IA intra-amniotic
I-FABP intestinal fatty acid binding protein
IQR interquartile range
LXR liver X receptor
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